Regulation of neuronal and glial galectin-1 expression by peripheral and central axotomy of rat primary afferent neurons.
Galectin-1 (Gal1) is an endogenously-expressed protein important for the embryonic development of the full complement of primary sensory neurons and their synaptic connections in the spinal cord. Gal1 also promotes axonal regeneration following peripheral nerve injury, but the regulation of Gal1 by axotomy in primary afferent neurons has not yet been examined. Here, we show by immunohistochemistry and in situ hybridization that Gal1 expression is differentially regulated by peripheral nerve injury and by dorsal rhizotomy. Following peripheral nerve injury, the proportion of Gal1-positive DRG neurons was increased. An increase in the proportion of large-diameter DRG neurons immunopositive for Gal1 was paralleled by an increase in the depth of immunoreactivity in the dorsal horn, where Gal1-positive terminals are normally restricted to laminae I and II. Dorsal rhizotomy did not affect the proportions of neurons containing Gal1 mRNA or protein, but did deplete the ipsilateral dorsal horn of Gal1 immunoreactivity, indicating that it is transported centrally by dorsal root axons. Dorsal rhizotomy also resulted in an increase in Gal1 mRNA the nerve peripheral to the PNS-CNS interface (likely within Schwann cells and/or macrophages), and to a lesser extent within deafferented spinal cord regions undergoing Wallerian degeneration. This latter increase was notable in the dorsal columns and along the prior trajectories of myelinated afferents into the deeper dorsal horn. These results show that neuronal and glial expressions of Gal1 are tightly correlated with regenerative success. Thus, the differential expression pattern of Gal1 following peripheral axotomy and dorsal rhizotomy suggests that endogenous Gal1 may be a factor important to the regenerative response of injured axons.
McGraw
J
J
ICORD (International Collaboration On Repair Discoveries), Department of Zoology, 6270 University Boulevard, University of British Columbia, Vancouver, Canada V6T 1Z4.
Gaudet
A D
AD
Oschipok
L W
LW
Kadoya
T
T
Horie
H
H
Steeves
J D
JD
Tetzlaff
W
W
Ramer
M S
MS
D000704:Analysis of Variance; D000818:Animals; D019771:Axotomy / Q000379:methods; D002452:Cell Count / Q000379:methods; D007839:Functional Laterality; D037483:Galectin 1 / Q000235:genetics / Q000378:metabolism*; D005727:Ganglia, Spinal / Q000473:pathology; D005786:Gene Expression Regulation / Q000502:physiology*; D006023:Glycoproteins / Q000378:metabolism; D007150:Immunohistochemistry / Q000379:methods; D017403:In Situ Hybridization / Q000379:methods; D037102:Lectins / Q000378:metabolism; D008297:Male; D009457:Neuroglia / Q000378:metabolism*; D009474:Neurons / Q000378:metabolism*; D010523:Peripheral Nervous System Diseases / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar; D019051:Rhizotomy / Q000379:methods; D013119:Spinal Cord Injuries / Q000473:pathology; D013997:Time Factors; D053675:Versicans
D037483:Galectin 1; D006023:Glycoproteins; D037102:Lectins; C508324:Vcan protein, rat; D053675:Versicans